Biotechnology

Filter

Current filters:

None

Popular Filters

90 to 114 of 2254 results

Bayer strikes deal with Dimension Therapeutics to develop hemophilia A gene therapy

23-06-2014

USA-based venture capital;-backed biotech Dimension Therapeutics has entered into a collaboration with…

BayerBiotechnologyDimension TheapeuticsHematologyLicensingResearch

JHL Biotech’s new $35 million financing will fund biosimilars

JHL Biotech’s new $35 million financing will fund biosimilars

22-06-2014

Taiwan biopharma company JHL Biotech say it has closed a Series B financing round of $35 million, led…

Asia-PacificBiosimilarsBiotechnologyFinancialJHL BiotechProductionResearch

Pharma and biotech sector leads the way in global M&A deals

Pharma and biotech sector leads the way in global M&A deals

20-06-2014

The pharma, medical and biotech industry is the most active sector for mergers and acquisitions so far…

BiotechnologyEuropeMergers & AcquisitionsPharmaceutical

France Biotech initiative to foster Franco-American connections

France Biotech initiative to foster Franco-American connections

20-06-2014

France Biotech, an association of entrepreneurs in the life sciences industry, today announced the launch…

BiotechnologyFinancialFranceResearchUSA

UK biotechs benefit from £100 million in Biomedical Catalyst funding

UK biotechs benefit from £100 million in Biomedical Catalyst funding

20-06-2014

UK biotech companies are leading the way to develop new therapies for cancer, Parkinson’s, diabetes…

BiotechnologyDavid Willetts MP , MinisterFinanceFinancialUK

Ablynx wins award for AbbVie deal at European Mediscience Awards

Ablynx wins award for AbbVie deal at European Mediscience Awards

20-06-2014

Belgian drug developer Ablynx has won the Transaction of the Year Award for its deal with US drugmaker…

AbbVieAblynxBelgiumBiotechnologyMergers & Acquisitions

BIND Therapeutics and Roche collaborate on discovery of novel nanomedicines

BIND Therapeutics and Roche collaborate on discovery of novel nanomedicines

19-06-2014

US clinical stage, investor backed biopharma company BIND Therapeutics (Nasdaq: BIND) has entered into…

BIND TherapeuticsBiotechnologyLicensingResearchRoche

Big pharma becomes a smaller employer while biotech booms

Big pharma becomes a smaller employer while biotech booms

19-06-2014

Big pharma employment dropped by 3% in the decade 2003-2013, allaying fears that industry consolidation…

BiotechnologyManagementPharmaceutical

Vertex licenses novel influenza treatment VX-787 to Janssen

Vertex licenses novel influenza treatment VX-787 to Janssen

18-06-2014

US biotech firm Vertex Pharmaceuticals has inked a deal with health care giant Johnson & Johnson subsidiary…

Anti-viralsBiotechnologyGlobalHealth Medical PharmaJanssenJohnson & JohnsonLicensingVertex PharmaceuticalsVX-787

3SBio licenses pegsiticase to Selecta Biosciences to develop the gout drug candidate

3SBio licenses pegsiticase to Selecta Biosciences to develop the gout drug candidate

18-06-2014

China-based biotech firm 3SBio has entered into an exclusive license with Selecta Biosciences for pegsiticase…

3SBioAnti-Arthritics/RheumaticsBiotechnologyLicensingpegsiticaseSelecta Biosciences

Isis Pharma earns $10 million milestone from Biogen

Isis Pharma earns $10 million milestone from Biogen

17-06-2014

Isis Pharmaceuticals revealed today it has earned a $10 million milestone payment from fellow US biotech…

Biogen IdecBiotechnologyFinancialIsis PharmaceuticalsNeurologicalResearch

US orphan status for Mirati’s mocetinostat and Alexion’s Soliris

US orphan status for Mirati’s mocetinostat and Alexion’s Soliris

17-06-2014

USA-based Mirati Therapeutics has been granted Orphan Drug designation by the US Food and Drug Administration…

BiotechnologyOncologyRare diseasesRegulation

Celgene exercises option for Agios Pharma’s AG-221

Celgene exercises option for Agios Pharma’s AG-221

17-06-2014

Metabolism specialist Agios Pharmaceuticals says that its partner, biotech major Celgene Corp, has exercised…

AG-221Agios PharmaceuticalsBiotechnologyCelgeneLicensingOncologyRegulationResearchUSA

Novartis files for US approval of meningitis B vaccine Bexsero

Novartis files for US approval of meningitis B vaccine Bexsero

17-06-2014

Swiss pharma major Novartis has submitted a Biologic License Application to the US Food and Drug Administration…

BexseroBiotechnologyNovartisRegulationUSAVaccines

Actelion shares leap on positive Ph III data with selexipag

Actelion shares leap on positive Ph III data with selexipag

16-06-2014

Shares of Switzerland-based Actelion, Europe’s largest biotech firm, gained 15.1% to 104.70 Swiss francs…

ActelionBiotechnologyResearchRespiratory and Pulmonaryselexipag

UK NICE consults on draft guidance for Gilead’s hepatitis C drug Sovaldi

UK NICE consults on draft guidance for Gilead’s hepatitis C drug Sovaldi

16-06-2014

In draft recommendations published today, UK health care watchdog the National Institute for Health and…

Anti-viralsBiotechnologyGilead SciencesPricingRegulationSovaldiUK

Doomed future for Tykerb in breast cancer arena, says analyst

Doomed future for Tykerb in breast cancer arena, says analyst

16-06-2014

The future of Tykerb (lapatinib) in the breast cancer market looks bleak, after the combination of GlaxoSmithKline’s…

BiotechnologyGlaxoSmithKlineMarkets & MarketingNovartisOncologyResearchTykerb

Takeda to withdraw NDA as Omontys pact with Affymax ends

Takeda to withdraw NDA as Omontys pact with Affymax ends

15-06-2014

USA-based Affymax and Japan's Takeda Pharmaceutical revealed on Friday that they have terminated their…

AffymaxBiotechnologyLicensingOmontysOncologyRegulationTakeda Pharmaceutical

Geron leaps as FDA lifts partial hold on imetelstat trial

Geron leaps as FDA lifts partial hold on imetelstat trial

13-06-2014

US biotech Geron Corp's shares jumped around 27% to $3.31 in early afternoon trading yesterday after…

BiotechnologyGeron CorpHematologyimetelstatOncologyRegulationUSA

90 to 114 of 2254 results

Back to top